Literature DB >> 16574327

Cartilage aggrecan undergoes significant compositional and structural alterations during laryngeal cancer.

Spyros S Skandalis1, Achilleas D Theocharis, Demitrios H Vynios, Nickoletta Papageorgakopoulou, Anders Hjerpe, Nikos K Karamanos, Dimitrios A Theocharis.   

Abstract

Aggrecan is a key component of cartilage and is responsible for the integrity and function of the tissue. In this study, the content of aggrecan and its structural modifications in adjacent to cancer apparently normal cartilages (AANCs) from various stages of laryngeal squamous cell carcinoma (LSCC) were investigated. Our data demonstrated a stage-related loss of aggregable aggrecan in AANCs, compared to the healthy laryngeal cartilage (HLC), which was excessive in advanced stages of disease. On aggregable aggrecan level, AANCs were characterized by significant compositional and structural modifications, the extent of which was closely related with the stage of LSCC. Four concrete subpopulations of aggregable molecules with particular physicochemical characteristics were identified with a strong tendency to prevail subpopulations of molecules of lower hydrodynamic sizes with increasing LSCC stage. These findings demonstrated that the cleavage of aggregable aggrecan occurred in concrete peptide bonds within the CS-1 and CS-2 attachment domains. These significant alterations were closely associated with the process of cartilage destruction, indicating the crucial role of aggrecan during LSCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574327     DOI: 10.1016/j.bbagen.2006.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas.

Authors:  Jochen Gaedcke; Marian Grade; Klaus Jung; Jordi Camps; Peter Jo; Georg Emons; Anastasia Gehoff; Ulrich Sax; Markus Schirmer; Heinz Becker; Tim Beissbarth; Thomas Ried; B Michael Ghadimi
Journal:  Genes Chromosomes Cancer       Date:  2010-11       Impact factor: 5.006

2.  The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: expressional and epigenetic studies.

Authors:  Dimitrios Kalathas; Irene-Eva Triantaphyllidou; Nicholas S Mastronikolis; Panos D Goumas; Thoedore A Papadas; Gabriel Tsiropoulos; Demitrios H Vynios
Journal:  Head Neck Oncol       Date:  2010-10-07

3.  Expression of genes encoding extracellular matrix proteins: a macroarray study.

Authors:  Konrad Futyma; Paweł Miotła; Krystyna Różyńska; Małgorzata Zdunek; Andrzej Semczuk; Tomasz Rechberger; Jacek Wojcierowski
Journal:  Oncol Rep       Date:  2014-09-17       Impact factor: 3.906

Review 4.  Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.

Authors:  Samira Aghlara-Fotovat; Amanda Nash; Boram Kim; Robert Krencik; Omid Veiseh
Journal:  Drug Deliv Transl Res       Date:  2021-06-26       Impact factor: 4.617

Review 5.  Proteoglycans-Biomarkers and Targets in Cancer Therapy.

Authors:  Dragana Nikitovic; Aikaterini Berdiaki; Ioanna Spyridaki; Theodoros Krasanakis; Aristidis Tsatsakis; George N Tzanakakis
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-06       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.